Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
Background This cost analysis uses data from a randomized trial comparing a no prophylaxis versus prophylactic platelet (PLT) transfusion policy (counts <10 × 109/L) in adult patients with hematologic malignancies.
Principais autores: | , , , , , , |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Blackwell Publishing Inc.
2014
|